Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

MONISTAT® Announces Quest to End Unfair Stigma of Yeast Infections

New survey shows unnecessary embarrassment is rampant; MONISTAT® urges women to get candid about candidiasis


News provided by

MONISTAT

Jan 30, 2013, 09:04 ET

Share this article

Share toX

Share this article

Share toX

TREVOSE, Pa., Jan. 30, 2013 /PRNewswire/ -- Research has shown that three in four women will experience candidiasis, more commonly known as a vaginal yeast infection, at some point in their lives. Yet despite the high incidence of the condition, a new independent survey commissioned by MONISTAT® revealed that more than two thirds (67%) of women believe that having a yeast infection is embarrassing.

"Yeast infections are a perfectly normal part of life for women," said Jennifer Moyer, vice president of marketing for INSIGHT Pharmaceuticals, LLC, the parent company of MONISTAT®. "A yeast infection doesn't mean you did anything wrong; it's like getting a cold. Yet our survey confirms that most women feel embarrassment about having a yeast infection. That's adding unnecessary distress to a normal condition, and one that's uncomfortable enough in its own right. So we are on a quest to end that embarrassment through education."

The survey, conducted by Harris Interactive, found that less than half of women surveyed (45%) feel comfortable talking openly about yeast infections with a friend. By contrast, the majority of women felt at least somewhat comfortable discussing menstruation (85%) and urinary tract infections (82%) with friends. Even more concerning, close to one in ten would not be comfortable talking openly about yeast infections with anyone, even their doctor.

Many women also think that suffering from a yeast infection is a cause for judgment: close to one-third (29%) of respondents indicated that they would be at least somewhat worried that other people would judge them if they knew they had experienced a yeast infection.

"We see many patients who are experiencing yeast infections, yet we find that women are often embarrassed to discuss their symptoms during appointments," said Dr. Allison Hill, OB/GYN and member of The Mommy Docs, a group of three doctors featured on the Oprah Winfrey Network's "Deliver Me" as well as a forthcoming eponymous series on public television. "As OB/GYNs, we see and hear everything. There is nothing a woman could reveal to us that would surprise or upset us, so there should be no reason for patients to be ashamed of having a yeast infection. It's imperative for women to feel comfortable enough to discuss topics like yeast infections with others, especially their doctor. After all, it's their own health at stake."

Other survey findings indicate that there are many misconceptions surrounding treatment options. More than one-third (36%) of women believe that yeast infections can be cured using a feminine cleansing product or cream designed exclusively to relieve itching and other symptoms; in reality, such products do not do anything to treat the infection. Furthermore, more than one in five women (23%) believe that yeast infections can only be cured with prescription treatment, when in actuality, over-the-counter products such as MONISTAT® are proven to be just as effective. Furthermore, MONISTAT® 1 provides relief from symptoms as soon as four hours after the first dose, which is four times faster than the leading prescription treatments.

"While we always recommend that women visit their doctor if they're experiencing a yeast infection for the first time to confirm the diagnosis, the condition is easily cured with over-the-counter treatments such as MONISTAT®," Dr. Hill continued. "Most yeast infections take around seven days to be completely cured, but if symptoms don't subside after a week, one may be experiencing another infection such as bacterial vaginosis, or an STD such as gonorrhea or chlamydia. In that case, a woman should see her doctor to confirm that it isn't something more serious."

"In our eyes, the unnecessary stigma of yeast infections is one of the last remaining injustices in women's health," Moyer stated. "The fact that so many women feel as though having a yeast infection is a cause for embarrassment when it's a decidedly normal part of life is something that needs to be rectified. By encouraging women to talk candidly about yeast infections, we hope to dispel some of the myths around the subject and ultimately empower women to take control of their personal health."

To learn more about vaginal yeast infections and treatment options offered by MONISTAT®, visit www.monistat.com. 

Abbreviated Methodology
This survey was conducted online within the United States by Harris Interactive on behalf of Neiman from October 11-15, 2012 among 1,152 female adults ages 18 and older. This online survey is not based on a probability sample and therefore no estimate of theoretical sampling error can be calculated. For complete survey methodology, including weighting variables, please contact Kaitlin Bitting at [email protected].

About MONISTAT®
MONISTAT® is the #1 doctor-recommended over-the-counter, antifungal yeast infection treatment that relieves symptoms and cures the infection. The Brand offers a portfolio of products, including 1-, 3- and 7-Day treatments, which are available in three forms – ovule, cream and suppository – and are designed to help women confidently address their vaginal health needs on their terms. The active ingredient in MONISTAT® is Miconazole Nitrate.  For a complete list of MONISTAT® products, visit www.monistat.com. 

About INSIGHT Pharmaceuticals:
INSIGHT Pharmaceuticals, LLC is a consumer products company whose strategy is to generate growth by acquiring brands with solid consumer equity that can be further developed through their merchandising and marketing expertise. The company strengthens its portfolio of brands by employing a variety of strategies, all with an in-depth understanding of the heritage of the brand and the needs of the consumer. Additional information about Insight Pharmaceuticals can be found at www.InsightPharma.com.

About the Mommy Docs:
Dr. Yvonne Bohn, Dr. Allison Hill, and Dr. Alane Park just celebrated the 10th anniversary of their OB/GYN practice in Los Angeles. They have personally welcomed more than 15,000 babies into the world. They are the featured doctors in the popular TV series "Deliver Me," in its third season on OWN: The Oprah Winfrey Network. They also have a new series "Mommy Docs" currently in development for public television. They know the pregnancy and birthing process intimately…from both sides. They're doctors, but they're also moms who have been through all the stages of pregnancy with six kids of their own. In addition to obstetric care they also provide guidance and treatment for various women's health concerns including: Contraceptive Health, Breast Cancer Screening, STD Screening, Menopausal Care, Infertility and Preventive health. For more information, visit www.MommyDocs.com or follow them on Twitter @TheMommyDocs.

Media Contact:

Company Contact:

Kaitlin Bitting 

Cassie Hallberg

Neiman 

INSIGHT Pharmaceuticals, LLC

Senior Business Partner – Public Relations 

Brand Director, MONISTAT®

[email protected] 

[email protected]

856-986-4206 

267-852-0542


 

SOURCE MONISTAT

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.